Idiopathic pulmonary fibrosis (IPF) is a progressive disease of the middle aged and elderly
with a prevalence of one million persons worldwide. The fibrosis spreads from affected …

A key feature of pulmonary fibrosis is the presence of fibroblasts at sites of active fibrosis. In
fact, the presence of a distinct lesion, termed a" fibroblastic focus," composed of fibroblasts …

Idiopathic pulmonary fibrosis (IPF) is a progressive, irreversible, and rapidly fatal interstitial
lung disease marked by the replacement of lung alveoli with dense fibrotic matrices …

Abstract Purpose of Review Idiopathic pulmonary fibrosis (IPF) is the most common form of
interstitial lung disease of unknown etiopathogenesis with mean survival of 3–5 years and …

Idiopathic pulmonary fibrosis (IPF) is a rare interstitial lung disease with a poor prognosis.
Chronic microinjuries, mainly caused by environmental factors to an aging alveolar …

Idiopathic pulmonary fibrosis (IPF) is a form of progressive interstitial lung disease with
unknown etiology. Due to a lack of effective treatment, IPF is associated with a high mortality …

Idiopathic pulmonary fibrosis (IPF) is a progressive and fatal lung disorder driven by
unrelenting extracellular matrix deposition. Fibroblasts are recognized as the central …

Idiopathic pulmonary fibrosis (IPF) is a progressive fibrotic lung disease, but the
mechanisms driving progression remain incompletely defined. We previously reported that …

Idiopathic pulmonary fibrosis (IPF) is a progressive and lethal disorder due to its unresolved
pathogenesis and limited responsiveness to currently available therapies. It is characterized …

Idiopathic pulmonary fibrosis (IPF) affects over 500,000 people in the United States and
Europe alone. The disease is characterized by progressive obliteration of normal alveolar …